MAPT and Alzheimer disease: Furthermore, multiple PET studies that focused on TSPO and amyloid or tau ligands discovered a strong association between the extent of neuroinflammation during the early stage of MCI and the levels of Aβ [43,44,45], highlighting the interplay between neuroinflammation and these key AD hallmarks.